Whitehawk Therapeutics, Inc. (WHWK) › Operating IncomeWhitehawk Therapeutics, Inc. (WHWK) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$20.5K2011: -$23.6K2012: -$22.4K2013: -$22.8K2014: -$24.0K2015: -$23.0K2016: -$16.63M2017: -$21.39M2018: -$11.18M2019: -$24.44M2020: -$2.55M2021: -$111.22M2022: -$62.68M2023: -$71.93M2024: -$67.46M2025: -$114.40M-$114.40M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$114.40M-69.6%2024-$67.46M+6.2%2023-$71.93M-14.8%2022-$62.68M+43.6%2021-$111.22M-4263.2%2020-$2.55M+89.6%2019-$24.44M-118.6%2018-$11.18M+47.7%2017-$21.39M-28.6%2016-$16.63M-72201.1%2015-$23.0K+4.0%2014-$24.0K-5.0%2013-$22.8K-1.9%2012-$22.4K+5.1%2011-$23.6K-15.0%2010-$20.5K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share